NEW YORK (TheStreet) -- Merck (MRK - Get Report) stock is gaining Tuesday after the pharmaceuticals company reported higher profits in its first quarter.
By early afternoon, shares were up 3% to $58.36.
The second-largest drugmaker in the U.S. earned an adjusted 88 cents a share, 9 cents higher than analysts polled by Thomson Reuters expected. Profitability was boosted over the quarter after research spending was cut 20 PERCENT to $1.5 billion.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Must Read: Jim Cramer on How Home Away (AWAY) Is Like Facebook (FB) and Google (GOOG)
However, total sales fell 4% to $10.26 billion, missing analyst forecasts by around $177 million. Results on the top line suffered from increased competition from generic brands particularly for its allergy and asthma treatments.
STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
WATCH: More market update videos on TheStreet TV | More videos from Keris Alison Lahiff